OpGen (OPGN): Prakiraan wutah bathi kanggo taun ngarep

OpGen, Inc. (OPGN) develops molecular analysis systems to combat antibiotic resistance. Analyst 12-month EPS growth targets confirm a crisis, where 0.00 reflects the metric's baseline. The Unyvero IT platform integrated rapid tests with AI databases, but the company is currently liquidating assets due to the bankruptcy of its European divisions and the failure to commercialize its developments.

OPGN - Proyeksi tambahing bathi saben saham ing taun ngarep OpGen Inc ing rentang 04.07.2022 - 31.08.2024

Rincian metrik lan analitis perusahaan opgen.com (OPGN)

- rega saham lan konsensus proyeksi valuasi:

Rega saham OpGen Corp|OPGN - Rata-rata rega prakiraan

- data kapitalisasi bursa:

Kapitalisasi pasar OpGen|OPGN - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- indikator kapitalisasi buku:

Nilai Akuntansi saben Saham OpGen|OPGN - Total Aset Bersih|Rasio Kapitalisasi Pasar marang Nilai Buku opgen.com|OPGN - Gunggung Aset Perusahaan

- data liabilitas lan likuiditas perusahaan:

- statistik bathi lan rasio pasar:

OPGN - Bathi sawise pajeg|Proyeksi bathi mangsa ngarep OpGen, Inc.|OPGN - Rasio kapitalisasi marang bathi resik|Pangali Forward P/E OpGen, Inc.|OPGN - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan OpGen|OPGN - Bathi operasional sadurunge amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan OpGen|OPGN - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan opgen.com|OPGN - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep OpGen, Inc.

Analisis umum perusahaan:OPGN, OpGen Corp

This indicator measures the dynamics of consensus earnings forecasts for the coming year, reflecting the amplitude of shifts in market expectations and the degree of transparency in corporate reporting. By analyzing the growth rate model for next year's earnings, an investor can assess volatility risks in demand for OpGen, Inc. (OPGN) molecular diagnostic systems and tests, where sharp fluctuations in the metric signal uncertainty regarding commercial prospects.

Analisis pesaing